II
ABBV icon

Inspire Investing’s AbbVie ABBV Stock Holding History

Inspire Investing’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-35,217
Closed -$2.56M – 376
2019
Q2 		$2.56M Buy
35,217
+383
+1% +$30.1K 1.08% 6
2019
Q1 		$2.81M Buy
34,834
+8,501
+32% +$695K 1.3% 5
2018
Q4 		$2.43M Buy
26,333
+3,365
+15% +$296K 1.63% 5
2018
Q3 		$2.17M Buy
22,968
+3,563
+18% +$338K 1.34% 6
2018
Q2 		$1.8M Buy
19,405
+15,903
+454% +$1.55M 1.28% 5
2018
Q1 		$331K Buy
3,502
+1,431
+69% +$157K 0.34% 32
2017
Q4 		$200K Buy
+2,071
New +$195K 0.17% 77

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Inspire Investing's ABBV Position: Q3 2019 in Review

Inspire Investing sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 35,217 shares — an estimated $2.56M sold.

Inspire Investing first reported a position in ABBV in Q4 2017 and held it in 7 quarters. The position peaked at $2.81M in Q1 2019. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Inspire Investing reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
  • Inspire Investing sold 35,217 AbbVie shares in Q3 2019, an estimated $2.56M.
  • Inspire Investing first reported a position in AbbVie in Q4 2017 and held it in 7 quarters.
  • Inspire Investing's AbbVie position peaked at $2.81M in Q1 2019.
  • 2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Inspire Investing's 13F filing for Q3 2019, filed 13 Nov 2019.